Class information for:
Level 1: B7 H4//B7 H3//SOLUBLE B7 H4

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
23216 354 36.6 93%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
919 2             PD L1//PD 1//FOXP3 11160
23216 1                   B7 H4//B7 H3//SOLUBLE B7 H4 354

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 B7 H4 authKW 6945543 25% 93% 87
2 B7 H3 authKW 6316407 24% 85% 86
3 SOLUBLE B7 H4 authKW 517544 2% 100% 6
4 CD276 authKW 431287 1% 100% 5
5 VTCN1 authKW 345030 1% 100% 4
6 B7X authKW 258772 1% 100% 3
7 B7 FAMILY authKW 249518 3% 32% 9
8 B7 H3 EXPRESSION authKW 172515 1% 100% 2
9 CANC IMMUNOTHER Y TECHNOL JIANGSU PROV address 172515 1% 100% 2
10 NUCLEAR B7 H3 authKW 172515 1% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 2541 44% 0% 156
2 Immunology 1131 28% 0% 99
3 Medicine, Research & Experimental 140 8% 0% 30
4 Cell Biology 99 10% 0% 37
5 Pathology 87 5% 0% 18
6 Transplantation 28 2% 0% 8
7 Cell & Tissue Engineering 24 1% 0% 3
8 Obstetrics & Gynecology 20 3% 0% 11
9 Biotechnology & Applied Microbiology 17 5% 0% 16
10 Gastroenterology & Hepatology 15 3% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANC IMMUNOTHER Y TECHNOL JIANGSU PROV 172515 1% 100% 2
2 TUMOR BIOL TREATMENT 161950 4% 14% 13
3 CLIN IMMUNOL JIANGSU PROV 100622 2% 17% 7
4 ABORAT INNOVAT RADIAT MEDMED 86257 0% 100% 1
5 AFFILIATED CANC HOSPXIANGYA MED RADIAT 86257 0% 100% 1
6 AFFILIATED NANJING SECOND HOSP 86257 0% 100% 1
7 ANAT TUMOUR IMMUNOL 86257 0% 100% 1
8 ANTIBODY DISCOVERY GRP 86257 0% 100% 1
9 BIESECKER PEDIATR LIVER 86257 0% 100% 1
10 BIOMED INSCANC I EM HYPOX DIS INS 86257 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ONCOLOGY LETTERS 1906 3% 0% 11
2 ONCOTARGETS AND THERAPY 1617 2% 0% 6
3 ONCOIMMUNOLOGY 1437 1% 0% 4
4 ONCOTARGET 996 3% 0% 12
5 TUMOR BIOLOGY 887 2% 0% 8
6 CANCER IMMUNOLOGY RESEARCH 764 1% 0% 2
7 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 739 2% 0% 7
8 CANCER IMMUNOLOGY IMMUNOTHERAPY 705 2% 0% 6
9 CLINICAL CANCER RESEARCH 567 3% 0% 10
10 CLINICAL AND EXPERIMENTAL MEDICINE 553 1% 0% 2

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 B7 H4 6945543 25% 93% 87 Search B7+H4 Search B7+H4
2 B7 H3 6316407 24% 85% 86 Search B7+H3 Search B7+H3
3 SOLUBLE B7 H4 517544 2% 100% 6 Search SOLUBLE+B7+H4 Search SOLUBLE+B7+H4
4 CD276 431287 1% 100% 5 Search CD276 Search CD276
5 VTCN1 345030 1% 100% 4 Search VTCN1 Search VTCN1
6 B7X 258772 1% 100% 3 Search B7X Search B7X
7 B7 FAMILY 249518 3% 32% 9 Search B7+FAMILY Search B7+FAMILY
8 B7 H3 EXPRESSION 172515 1% 100% 2 Search B7+H3+EXPRESSION Search B7+H3+EXPRESSION
9 NUCLEAR B7 H3 172515 1% 100% 2 Search NUCLEAR+B7+H3 Search NUCLEAR+B7+H3
10 SB7 H4 172515 1% 100% 2 Search SB7+H4 Search SB7+H4

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 PICARDA, E , OHAEGBULAM, KC , ZANG, XX , (2016) MOLECULAR PATHWAYS: TARGETING B7-H3 (CD276) FOR HUMAN CANCER IMMUNOTHERAPY.CLINICAL CANCER RESEARCH. VOL. 22. ISSUE 14. P. 3425 -3431 53 82% 1
2 WANG, L , KANG, FB , SHAN, BE , (2014) B7-H3-MEDIATED TUMOR IMMUNOLOGY: FRIEND OR FOE?.INTERNATIONAL JOURNAL OF CANCER. VOL. 134. ISSUE 12. P. 2764-2771 46 74% 25
3 WANG, LJ , HENG, XY , LU, Y , CAI, Z , YI, Q , CHE, FY , (2016) COULD B7-H4 SERVE AS A TARGET TO ACTIVATE ANTI-CANCER IMMUNITY?.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 38. ISSUE . P. 97 -103 43 83% 1
4 YE, ZM , ZHENG, ZJ , LI, XD , ZHU, YD , ZHONG, ZP , PENG, LR , WU, YY , (2016) B7-H3 OVEREXPRESSION PREDICTS POOR SURVIVAL OF CANCER PATIENTS: A META-ANALYSIS.CELLULAR PHYSIOLOGY AND BIOCHEMISTRY. VOL. 39. ISSUE 4. P. 1568 -1580 45 78% 0
5 YI, KH , CHEN, LP , (2009) FINE TUNING THE IMMUNE RESPONSE THROUGH B7-H3 AND B7-H4.IMMUNOLOGICAL REVIEWS. VOL. 229. ISSUE . P. 145-151 37 77% 73
6 SONG, X , SHAO, YJ , GU, WD , XU, C , MAO, HH , PEI, HL , JIANG, JT , (2016) PROGNOSTIC ROLE OF HIGH B7-H4 EXPRESSION IN PATIENTS WITH SOLID TUMORS: A META-ANALYSIS.ONCOTARGET. VOL. 7. ISSUE 47. P. 76523 -76533 31 82% 1
7 FAUCI, JM , STRAUGHN, JM , FERRONE, S , BUCHSBAUM, DJ , (2012) A REVIEW OF B7-H3 AND B7-H4 IMMUNE MOLECULES AND THEIR ROLE IN OVARIAN CANCER.GYNECOLOGIC ONCOLOGY. VOL. 127. ISSUE 2. P. 420-425 35 78% 15
8 YU, N , LI, XM , ZHENG, SG , LI, XP , (2013) B7-H4'S ROLE "BEYOND THE TUMOR".INFLAMMATION. VOL. 36. ISSUE 4. P. 941-947 37 74% 3
9 HE, CJ , QIAO, HQ , JIANG, HC , SUN, XY , (2011) THE INHIBITORY ROLE OF B7-H4 IN ANTITUMOR IMMUNITY: ASSOCIATION WITH CANCER PROGRESSION AND SURVIVAL.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - 31 82% 23
10 CEERAZ, S , NOWAK, EC , NOELLE, RJ , (2013) B7 FAMILY CHECKPOINT REGULATORS IN IMMUNE REGULATION AND DISEASE.TRENDS IN IMMUNOLOGY. VOL. 34. ISSUE 11. P. 556 -563 46 41% 50

Classes with closest relation at Level 1


Rank Class id link
1 24008 ICOS//B7RP 1//INDUCIBLE COSTIMULATOR
2 721 PD L1//PD 1//IPILIMUMAB
3 30415 RCAS1//EBAG9//RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS
4 4080 REGULATORY T CELLS//FOXP3//TUMOR INFILTRATING LYMPHOCYTES
5 2395 CD28//COSTIMULATION//B7
6 28365 VSIG4//TRANSPLANTABLE MELANOMAS//CRIG
7 10449 LYMPHOTOXIN//BTLA//TERTIARY LYMPHOID ORGANS
8 35146 TNFRSF21//ARA267 ALPHA//BIO THER EUT DISCOVERY
9 36322 5 HT2C AND 5 HT2A RECEPTORS//HALOSTEROL A//HALOSTEROL B
10 8384 4 1BB//OX40//CD137

Go to start page